Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Repurchase of own shares

Tietoevry Corporation          STOCK EXCHANGE RELEASE          23 February 2023  7.00 p.m. EET   Date:  23 February 2023 Exchange transaction: Buy                       Share class:  TIETO Amount, shares: 41 699 Average price/share, EUR 30.1178 Total price, EUR: 1 255 882.14   The number of shares held by Tietoevry Corporation after the completion of transactions: 251 865 shares.                         On behalf of Tietoevry Corporation        EVLI PLC                Joachim Dannberg                  For further information, please

ODI Pharma AB: Publication of half-year report 2022/2023

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2022. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Second quarter (2022-10-01 – 2022-12-31) The Group's net sales amounted to SEK 73,276 (458,620). The Group's loss after financial items amounted to SEK -1,735,431 (-1,401,502). Result per share amounted to SEK -0.11 (-0.09).* Six months (2022-07-01 – 2022-12-31) The Group’s net sales amounted to SEK 101,282 (458,

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 23.02.2023

United Bankers Plc NOTIFICATION   23.02.2023 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 23.02.2023   Date 23.02.2023  Exchange transaction Buy  Share class UNITED  Amount 380  Average price/share 14.9342 EURHighest price/share 15.0000 EURLowest price/share 14.9000 EURTotal price 5,675.00 EUR        The shares held by United Bankers Plc on 23.02.2023   UNITED 25,448         On behalf of United

Clinical Laserthermia Systems AB enters underwriting commitments in the ongoing exercise of warrants of series TO 5 B corresponding to approximately SEK 2.6 million

Lund, Sweden – Clinical Laserthermia Systems AB ("CLS" or the "Company") hereby announces that the Company has agreed on underwriting commitments (so-called “top-down” or “top guarantee”) in the ongoing exercise of warrants of series TO 5 B ("TO 5 B”). The underwriting commitments covers a total of approx. SEK 2.6 million, corresponding to 20 percent of the issue proceeds that the Company can receive through the exercise of TO 5 B. The underwriters have also undertaken to exercise their TO 5 B to subscribe for new B-shares in CLS, corresponding to a total of approximately SEK 100,000.In the

Financial report for the 4th quarter 2022

· A quarter with high utilization and improved commercial terms across all geographical regions and vessel segments compared to 4Q 2021. · The market continues to strengthen despite a challenging macroeconomic environment. · Revenues for 4Q 2022 increased by 26 percent to MNOK 1,637 vs MNOK 1,303 in 4Q 2021. · EBITDA adjusted increased by 56 percent to MNOK 454 vs MNOK 291 in 4Q 2021. · The quarter experienced positive impact to equity following the strengthening of NOK against USD. · The highest quarterly order intake in the Company’s history with contracts signed for

Clinical Laserthermia Systems AB publishes Year-end report January – December 2022

Summary of the year-end report (relates to the Group)   Twelve months (01/01/2022–12/31/2022) · Net sales totaled SEK 6,268,000 (SEK 2 245,000). · Profit/loss after financial items totaled SEK -71,265,000 (SEK -64,141,000). · Basic and diluted earnings per share totaled SEK -0.85 (SEK -1.12). · The equity ratio at December 31, 2022, was 18,6% (31,7%).   Fourth quarter (10/01/2022–12/31/2022) · Net sales totaled SEK 4,295,000 (SEK 1,344,000). · Profit/loss after financial items amounted to SEK -19,618,000 (SEK -19,584,000). · Basic and diluted earnings per

Borr Drilling Limited – SGM Results Notification

Borr Drilling Limited (the “Company”) (NYSE and OSE: “BORR”) advises that a Special General Meeting of the Company was held on February 23, 2023 at 09:00 ADT at 2nd Floor, The S.E. Pearman Building, 9 Par-la-Ville Road, Hamilton HM 11, Bermuda. The following resolution was passed: To approve the increase of the Company’s authorized share capital from US$25,500,000.00 divided into 255,000,000 common shares of US$0.10 par value each to US$31,500,000.00 divided into 315,000,000 common shares of US$0.10 par value each by the authorization of an additional 60,000,000 common shares of US$0.

DEKRA temporarily suspends certificates for Getinge’s HLS and PLS sets

The notified body for certification services, DEKRA, has decided to temporarily suspend the CE-certificates for Getinge’s HLS and PLS sets from March 1, 2023. Getinge is in dialogue with authorities and working urgently to minimize the impact on patients.As previously communicated, Getinge has identified and announced potential breaches in sterile packaging of the HLS and PLS sets used for extracorporeal respiratory and/or cardiovascular support. Getinge has since then reported progress to relevant authorities on a number of initiatives, such as package design improvements and advanced

Storskogen extends credit facility agreements

Storskogen Group AB (publ) extends, in full, both of its outstanding unsecured facility agreements by one year each. The extension includes both the revolving credit facility entered into on 24 September 2021 of EUR 1 billion, which is extended until 24 September 2025, and the unsecured syndicated term facility agreement entered into on 23 September 2022 of EUR 300 million which is extended until 24 March 2025. All banks in each facility agreement have partaken in the extension. After the extension, the revolving credit facility has another extension option of one year.The facility

Panel talk about Inify's fourth quarter 2022

From the heart of their brand-new laboratory comes this panel talk with CEO Fredrik Palm and CTO Arto Järvinen of Inify Laboratories. Here, they discuss progress made so far and how the Systems Engineering methodology ensures that all components - from internal IT to equipment and logistics - fit together in one seamless clinical workflow.During the last quarter of 2022, Inify Laboratories moved into its brand-new premises at Campus Solna just outside of Stockholm. The laboratory was finished in record time and all essential milestones were reached, in terms of both laboratory

#23-64 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Children’s lung capacity improved in cleaner air

As air pollution in Stockholm has decreased, so has the lung capacity of children and adolescents has improved, a new study published in the European Respiratory Journal reports. The researchers from Karolinska Institutet consider the results important, since the lung health of the young greatly affects the risk of their developing chronic lung diseases later in life.“Fortunately, we’ve seen a decrease in air pollutants and therefore an increase in air quality in Stockholm over the past 20 years,” says the study’s last author Erik Melén, paediatrician and professor at the Department of

Aqualung Carbon Capture Announces Denbury as Strategic Investor

Oslo, Norway (22 February 2023) – Aqualung Carbon Capture (“Aqualung”), a leader in membrane carbon dioxide (CO2) capture and separation technology, is excited to announce the strategic carbon capture and sequestration partnership with Denbury Inc (“Denbury” NYSE: DEN), the world’s largest CO2 pipeline operator.  In conjunction with the partnership, Denbury will make an equity investment in Aqualung, expanding on our strong shareholder base.  Aqualung’s CO2 capture technology has demonstrated the ability to significantly reduce the cost of capture utilizing our membrane technology and is

Notification regarding Ambea’s holding of own shares

After repurchases completed in accordance with a share repurchase program resolved on by the board of directors of Ambea AB (publ), the company’s holding of own shares on 22 February 2023 amounted to 4 757 388 shares, which corresponds to 5,03 percent of the total numbers of shares and votes in the company. The company’s holding of own shares thus exceeds five percent of the total numbers of shares and votes in the company.The repurchases of own shares have been made by virtue of an authorisation from the Annual General Meeting 2022 to repurchase shares and in accordance with the board of

New registration needed to receive news from PowerCell Sweden AB

We have changed service for the distribution of our press releases. If you would like to continue receiving company news in your inbox, you will need to sign up here: https://powercellgroup.com/investor/ Recent press releases from PowerCell Sweden AB:2023-02-09We have established ourselves as a growth company in a sector driven by strong megatrendshttps://powercellgroup.com/press-releases/we-have-established-ourselves-as-a-growth-company-in-a-sector-driven-by-strong-megatrends/ 2023-02-08PowerCell will establish a local US presence as a result of growing demand from customers

Swedbank Mortgage’s Annual Report 2022 published

Swedbank Mortgage’s Annual Report for 2022 has been published at Swedbank’s website.    Swedbank Mortgage AB (in Swedish: Swedbank Hypotek) is a wholly owned subsidiary to Swedbank AB (publ). Mortgages are distributed through Swedbank’s and the Swedish savings banks´ branches as well as digital channels.   Swedbank Mortgage AB (publ) is required to disclose this information pursuant to the Swedish Securities Markets Act (2007:528). This information was sent to be

Fabege continues to reduce its carbon footprint with a new agreement

Fabege has signed an agreement with Stockholm Exergi concerning the capturing of biogenic carbon dioxide, which is known as bio-CCS (carbon capture and storage) and the future purchasing of negative emissions. The memorandum of understanding is an important step towards achieving Fabege's 2030 climate goals.Fabege currently has greenhouse gas emissions linked to the purchasing of district heating, and Stockholm Exergi is one of the largest suppliers. Stockholm Exergi’s research project, which has state and EU funding, is part of an international collaboration that is aiming to further

Lundbergs Year-End Report 2022

· On December 31, 2022, net asset value after deferred tax amounted to SEK 119.0 billion (SEK 480 per share), compared with SEK 132.3 billion (SEK 533 per share) on December 31, 2021. The corresponding values on February 21, 2023 were SEK 125.7 billion (SEK 507 per share).  · Consolidated net sales amounted to SEK 29,193 m. (24,832).  · Profit after financial items amounted to SEK 7,679 m. (17,134) where earnings from participation in associated companies and joint ventures amounted to SEK -1,688 m. (5,814). Profit after financial items excluding unrealized changes in value

Arctic Bioscience – Mandatory notification of trade

Runhild Gammelsæter, Medical Director in Arctic Bioscience, has today bought 11,500 shares in Arctic Bioscience at an average price of NOK 13.90 per share. Following the transaction, Runhild Gammelsæter holds 24,774 shares and 101,570 share options in Arctic Bioscience.Please refer to the attached notification of trading for further details.  This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

CORRECTION: Higher currency adjusted growth than earlier noted – I-Tech AB (publ) Year-end report 2022

I-Tech AB (publ) (ticker ITECH) publish the year-end report 2022  Click here on the 22th of February 2022, at 10.30 to follow the webcast  Click here to go directly to I-Tech's Financial Reports I-Tech AB (publ) issues a correction to the press release that was published yesterday, February 22. The correction is related to that the currency adjusted growth for quarter 4 amounts to 120.8% compared to 85.4% which was earlier noted. Fur the full year it amounts to 33.3% compared to earlier

Valmet to supply a coated board machine to Graphic Packaging International in the United States

Valmet Oyj’s press release on February 23, 2023 at 3:00 p.m. EETValmet will supply a coated board machine for Graphic Packaging International (GPI) in the United States. Valmet delivered a similar coated board machine to GPI’s Kalamazoo mill in 2022. The new machine will be supplied to GPI’s mill in Waco, Texas. The start-up of the machine is scheduled for early 2026. The order is included in Valmet's orders received of the first quarter 2023. Its value will not be disclosed, but an order of this type and scope is typically valued between EUR 140 and 180 million. With this investment

Corem divests 17 properties in Stockholm for SEK 949 millio

Corem has signed an agreement to divest 17 properties in the Stockholm area at a total underlying property value of SEK 949 million. Most of the properties are located in Täby and Upplands-Väsby just north of Stockholm and four properties are located south of Stockholm in Huddinge, Botkyrka and Älvsjö. The properties have a lettable area of approximately 65,000 sq.m. and consist mainly of premises for offices and warehouses. The rental value amounts to approximately SEK 79 million and the economic occupancy rate amounts to approximately 95 per cent.Transfer of possession is planned to

Year-end Report 2022

Increased sales and strong earnings Quarterly net sales increased by 22 percent and EBITDA before items affecting comparability increased by 135 percent, due to organic and acquisition growth. Price increases for fuel and raw materials continue to put pressure on margins. Continued strong quarterly cash flow from operating activities. In 2022, annual net sales increased by 35 percent and EBITDA before items affecting comparability increased by 43 percent. The acquisition strategy remains firm, focusing on identified growth regions in Sweden."We can conclude that the fourth

Terrafame Ltd publishes its January–December 2022 result on 3 March

The battery chemicals producer Terrafame Ltd publishes its January–December 2022 result on Friday 3 March 2023 approximately at 9:00 a.m. Finnish time. The report will be available on the company’s website at www.terrafame.com after publishing. A briefing in Finnish for media representatives will be held on the same day at 11 a.m. at the Lilla Roberts Hotel in Helsinki (Selim Auditorium, Pieni Roobertinkatu 1-3). At the briefing, CEO Joni Lukkaroinen will present the company's result. After that, Lauri Ratia, Chairman of the Board of Terrafame Ltd, will talk about company’s journey to

There are no items matching the current filter
There are no more items matching the current filter
Back to top